Design of a Double-Blind, Placebo- and Active-Controlled, Phase-Iii Trial in Patients with Parkinson's Disease and End-Of-Dose Motor Fluctuations: Opicapone Superiority Vs. Placebo and Non-Inferiority Vs. Entacapone
16Th Congress of the European-Federation-Of-Neurological-Societies (Efns), Date: SEP 08-11, 2012, Location: Stockholm, SWEDEN, Sponsors: European Federat Neurol Soc (EFNS)
